Leveraging Patient-Derived Models for Immunotherapy Research.

American Society of Clinical Oncology Educational Book
Katerina Politi

Abstract

As cancer immunotherapies become mainstream for the treatment of many different cancer types and the numbers of new agents continue to increase, the need for experimental models is also rising. An approach to develop and study models for immune-oncology that has garnered intense interest in recent years is that of using patient-derived models. Patient-derived models can recapitulate many of the features and heterogeneity of the corresponding human tumors. Historically these models have been used to study cancer cell-intrinsic properties of tumors and drugs that target tumor cells directly. In recent years, increasing recognition of the role immune cells play in cancer and how these represent good therapeutic targets has led to efforts to optimize and use patient-derived models for cancer immunotherapy studies. Patient-derived models are now being used to study the properties of cancer cells that modulate their ability to respond to immune stimulation. Further efforts are underway to use and develop patient-derived models that incorporate human immune cells in vitro and in vivo (humanized mice) so that cancer cell-immune cell interactions can be studied in the context of cancer immunotherapies. As these models are further refine...Continue Reading

References

Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier Mestas, Christopher C W Hughes
May 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leonard D ShultzRupert Handgretinger
Jan 30, 2007·Nature Reviews. Immunology·Leonard D ShultzDale L Greiner
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Leonard D ShultzFumihiko Ishikawa
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tim WillingerRichard A Flavell
Jan 22, 2013·Annual Review of Immunology·Anthony RongvauxMarkus G Manz
Aug 21, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ryoji ItoMamoru Ito
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qunrui YeDaniel J Powell
Mar 19, 2014·Nature Biotechnology·Anthony RongvauxRichard A Flavell
Feb 26, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ikumi KatanoMamoru Ito
Feb 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marina BacacPablo Umana
Jul 20, 2016·The New England Journal of Medicine·Jesse M ZaretskyAntoni Ribas
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·David G McFaddenHarold Varmus
Dec 3, 2016·Cancer Discovery·Daniel Sanghoon ShinAntoni Ribas
Jan 21, 2017·Nature Reviews. Cancer·Annette T ByrneLivio Trusolino
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Dietmar Herndler-BrandstetterRichard A Flavell
Nov 3, 2017·Cancer Research·Terrence F MeehanCarol J Bult
Nov 5, 2017·Cancer Discovery·Russell W JenkinsDavid A Barbie
Nov 18, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Minan WangJames G Keck
Nov 21, 2017·Cellular & Molecular Immunology·Tomonori YaguchiYutaka Kawakami
Aug 6, 2018·Trends in Immunology·Philippe De La RochereEliane Piaggio
Oct 13, 2018·Cancer Discovery·Brian OlsonAkash Patnaik
Oct 26, 2018·Nature·Tzachi HagaiSarah A Teichmann
Nov 30, 2018·Nature Reviews. Drug Discovery·Jun TangYunqing Lin
Dec 15, 2018·Cell·James T NealCalvin J Kuo
Oct 2, 2019·Nature Reviews. Immunology·Anusha Kalbasi, Antoni Ribas
Nov 30, 2019·Nature Reviews. Drug Discovery·Jia Xin YuJun Tang
Jan 18, 2020·Methods in Enzymology·Jordan J CardenasKaterina Politi
Mar 18, 2020·Methods in Enzymology·Chun I YuKarolina Palucka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.